Results 1 to 10 of about 93,603 (306)

Treatment resistant depression in women with peripartum depression [PDF]

open access: yesBMC Pregnancy and Childbirth, 2019
Background Peripartum depression is a leading cause of disease burden for women and yet there is little evidence as to how often peripartum depression does not respond to treatment and becomes treatment resistant depression.
M. Soledad Cepeda   +2 more
doaj   +3 more sources

Neuromodulation therapies and treatment-resistant depression

open access: yesMedical Devices: Evidence and Research, 2012
Khalid Saad Al-Harbi,1 Naseem Akhtar Qureshi21National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia; 2General Administration for Research and Studies and Mental Health and Social Services, Riyadh, Saudi ArabiaBackground: Patients ...
Al-Harbi KS, Qureshi NA
doaj   +1 more source

Treatment-resistant depression: therapeutic trends, challenges, and future directions

open access: yesPatient Preference and Adherence, 2012
Khalid Saad Al-HarbiMedical College, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi ArabiaBackground: Patients with major depression respond to antidepressant treatment, but 10%–30%
Al-Harbi KS
doaj   +2 more sources

Ketamine for treatment resistant depression in individuals with eating disorders: a comparison study [PDF]

open access: yesJournal of Eating Disorders
Background Individuals with eating disorders (EDs) have an increased risk of treatment resistant depression (TRD) and treatment resistant bipolar disorder (TRBD) and a higher rate of suicidal ideation and death by suicide than individuals without EDs ...
Elizabeth Wassenaar   +7 more
doaj   +2 more sources

CHALLENGES OF TREATMENT-RESISTANT DEPRESSION

open access: yesPsychiatria Danubina, 2018
Guidelines for the management of treatment-resistant depression (TRD) do not meet the criteria of evidence-based medicine and better-quality research is required to inform clinical practice.
Pandarakalam, James Paul   +1 more
core   +4 more sources

The role of immunomodulators in treatment-resistant depression: case studies

open access: yesCell Death Discovery, 2022
Depression is a common mental disorder affecting more than 264 million people worldwide. The first-line treatment for most cases of depression are selective serotonin reuptake inhibitors (SSRIs), such as sertraline, reboxetine and fluoxetine.
Charles W. Beckett   +1 more
doaj   +2 more sources

Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

open access: yesWorld Psychiatry, 2023
Treatment-resistant depression (TRD) is common and associated with multiple serious public health implications. A consensus definition of TRD with demonstrated predictive utility in terms of clinical decision-making and health outcomes does not currently
Josefina Ly-Uson
exaly   +1 more source

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT

open access: yesFrontiers in Psychiatry, 2023
IntroductionAmong treatment-resistant depression (TRD), we identified anergic-anhedonic clinical presentations (TRAD) as putatively responsive to pro-dopaminergic strategies.
Ludovic Christophe Dormegny-Jeanjean   +47 more
doaj   +1 more source

Ketamine in treatment-resistant depression

open access: yesIndustrial Psychiatry Journal
Sana Dhamija   +2 more
doaj   +5 more sources

Treatment-resistant depression reconsidered

open access: yesSSM - Mental Health, 2022
The term treatment-resistant depression (TRD) has been the focus of hundreds of studies and clinical trials, though it is not a diagnosable mental health condition according to current clinical standards.
Hans S. Schroder   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy